# DESCRIPTION

## BACKGROUND

- introduce metabotropic glutamate receptors
- describe receptor structure
- explain receptor function
- discuss ligands and their effects
- mention potential therapeutic applications
- provide background references

## SUMMARY

- introduce method for modulating mGluR activity
- describe orthosteric and allosteric drugs
- mention potential therapeutic applications
- introduce method for treating diseases
- describe administering calcium agents
- discuss dosage and formulation
- mention composition and optimal amounts

## DETAILED DESCRIPTION

- introduce mGluR1α and its sensing of [Ca2+]o
- describe mGluR1-mediated activation of Ca2+-activated Cl− channels
- discuss modulation of mGluR1 activity by [Ca2+]o
- identify [Ca2+]o-binding site in the hinge region of the ECD of mGluR1α
- describe the role of D318, E325, D322, and L-Glu in [Ca2+]o binding
- discuss synergistic modulation of mGluR1α by L-Glu and Ca2+
- examine the effect of mutating L-Glu- and Ca2+-binding sites on mGluR1α activity
- investigate the role of [Ca2+]o in modulating the actions of orthosteric ligands
- study the interaction between Ca2+ and mGluR1 allosteric modulators
- discuss the enhancement of [3H]-L-Quis binding to mGluR1α by [Ca2+]o
- examine the effect of (s)-MCPG on mGluR1α activity
- discuss the potentiation of Ro-674853 by [Ca2+]o
- describe the inhibition of mGluR1α by CPCCOEt
- summarize the modulation of mGluR1α activity by [Ca2+]o
- introduce orthosteric and allosteric mGluR modulators
- describe the use of orthosteric agonists and antagonists of mGluR
- discuss the use of allosteric modulators of mGluR
- introduce extracellular calcium modulators
- describe the use of calcium agents to modulate extracellular calcium levels
- discuss the effect of calcium levels on mGluR activity
- introduce calcium supplements
- describe the absorption of calcium from the gastrointestinal tract
- discuss the role of vitamin D in calcium absorption
- introduce neurotransmitters or amino acids that affect mGluR sensitivity to calcium
- describe the effect of L-glutamate on mGluR activity
- introduce electric or mechanical stimulation as a calcium agent
- discuss the use of biosensors to measure extracellular calcium levels
- describe the adjustment of extracellular calcium levels to optimal levels
- introduce methods of treatment using disclosed compositions and methods
- discuss the treatment of neurological and psychiatric disorders
- describe the treatment of cognitive disorders and anxiety disorders
- summarize the treatment of various diseases and disorders using disclosed compositions and methods
- introduce therapeutic agents for CNS disorders
- describe combinations of disclosed compositions with other therapeutic agents
- list examples of therapeutic agents for combination therapy
- describe administration of disclosed compositions with sedatives, hypnotics, anxiolytics, antipsychotics, and antidepressants
- list examples of sedatives, hypnotics, anxiolytics, antipsychotics, and antidepressants
- describe administration of disclosed compositions with levodopa and other neuroleptic agents
- list examples of neuroleptic agents
- describe administration of disclosed compositions with anoretic agents
- list examples of anoretic agents
- describe administration of disclosed compositions with antidepressant or anti-anxiety agents
- list examples of antidepressant or anti-anxiety agents
- describe administration of disclosed compositions with opiate agonists, lipoxygenase inhibitors, and other agents
- list examples of opiate agonists, lipoxygenase inhibitors, and other agents
- introduce dosage forms of pharmaceutical compositions
- describe preparation of pharmaceutical compositions
- list examples of excipients for tablets
- describe coating of tablets
- describe hard gelatin capsules
- describe soft gelatin capsules
- describe aqueous suspensions
- list examples of suspending agents
- describe oily suspensions
- describe dispersible powders and granules
- describe oil-in-water emulsions
- describe syrups and elixirs
- describe sterile injectable aqueous solutions, micellar formulations, and oleaginous suspensions
- describe vehicles and solvents for injectables
- introduce therapeutically effective amounts of mGluR orthosteric or allosteric drug
- describe dosage levels
- describe dosage regimens
- describe factors affecting dosage regimens
- introduce therapeutic administration of disclosed compositions
- describe routes of administration
- describe formulation of disclosed compositions
- describe carriers, adjuvants, and vehicles for administration
- describe oral administration
- describe parenteral administration
- describe inhalation administration
- describe topical administration
- conclude therapeutic administration of disclosed compositions

### DEFINITIONS

- define selective agents
- define orthosteric ligands
- define allosteric ligands
- explain affinity
- define allosteric modulators
- define subject and patient
- define therapeutically effective
- define pharmaceutically acceptable

### EXAMPLES

- introduce experimental procedures
- dock L-Quis to ECD-mGluR1α using Autodock-Vina
- analyze binding residues using Dymdon
- perform MD simulation and correlation analysis using Amber
- construct mGluR1α variants with site-directed mutagenesis
- express mGluR1α variants in HEK293 cells
- measure effect of [Ca2+]o on activation of mGluR1α by L-Quis
- measure [Ca2+]i responses to L-Glu or L-Quis
- determine effect of [Ca2+]o on potency of Ro 67-4853
- measure [Ca2+]i responses in presence of CPCCOEt
- determine effect of [Ca2+]o on [3H]-L-Quis binding
- analyze predicted [Ca2+]o-binding site
- model binding site for L-Quis using Autodock-Vina
- analyze correlation between [Ca2+]o-binding site and L-Glu-binding site
- perform molecular dynamics simulations
- analyze correlation between [Ca2+]o-binding site and L-Quis-binding site
- determine effect of [Ca2+]o on activation of mGluR1α by L-Quis
- analyze effect of [Ca2+]o on L-Quis CRC
- test effect of [Ca2+]o on activation of mGluR1α variants
- analyze effect of [Ca2+]o on L-Quis binding to mGluR1α variants
- determine effect of (s)-MCPG on sensitivity of mGluR1α to L-Glu
- analyze effect of (s)-MCPG on L-Glu CRC
- determine effect of (s)-MCPG on sensitivity of mGluR1α to [Ca2+]o
- analyze effect of (s)-MCPG on [Ca2+]o CRC
- test effect of CPCCOEt on L-Glu-induced [Ca2+]i response
- analyze effect of CPCCOEt on L-Glu CRC
- test effect of CPCCOEt on [Ca2+]o-induced [Ca2+]i response
- analyze effect of CPCCOEt on [Ca2+]o CRC
- determine effect of Ro 67-4853 on activation of mGluR1α by [Ca2+]o
- analyze effect of Ro 67-4853 on [Ca2+]o CRC
- summarize predicted [Ca2+]o-binding site
- summarize correlation between [Ca2+]o-binding site and L-Glu-binding site
- summarize effect of [Ca2+]o on activation of mGluR1α by L-Quis
- summarize effect of [Ca2+]o on L-Quis binding to mGluR1α
- summarize effect of (s)-MCPG on sensitivity of mGluR1α to L-Glu and [Ca2+]o
- summarize effect of CPCCOEt on L-Glu-induced and [Ca2+]o-induced [Ca2+]i responses
- summarize effect of Ro 67-4853 on activation of mGluR1α by [Ca2+]o
- conclude that [Ca2+]o regulates effects of orthosteric ligands on mGluR1α
- introduce mGluR1α
- describe Ca2+ binding site
- motivate Ca2+ effect on mGluR1α
- describe L-Glu-induced activation
- show Ca2+ enhancement of L-Glu binding
- discuss Ca2+ release from ER
- describe Ca2+ influx through store-operated channels
- show Ca2+ effect on L-Quis binding
- discuss Ca2+ modulation of orthosteric ligands
- describe predicted Ca2+ binding site
- show correlation between Ca2+ binding site and orthosteric binding sites
- discuss conservation of Ca2+ binding site
- describe effect of Ca2+ on responses to orthosteric agonists and antagonists
- discuss Molecular Dynamics studies
- describe effect of Ca2+ on allosteric modulators
- show CPCCOEt inhibition of L-Glu response
- describe Ca2+ restoration of CPCCOEt sensitivity
- discuss potential therapeutic effect of CPCCOEt
- describe Ro 67-4853 enhancement of L-Glu response
- show Ca2+ reduction of Ro 67-4853 EC50 value
- discuss allosteric interaction between Ca2+ binding site and Ro 67-4853 site
- describe E325I mutation effect on Ca2+ modulation of Ro 67-4853
- discuss integrated action of ECD and TMDs
- describe potential of Ca2+ to modulate profile of agents acting on mGluR1α
- introduce Example 2
- describe Methods for Example 2
- describe mGluR5 transfection and Fura-2 loading
- describe fluorescence microscopy measurement
- show Ca2+ induction of intracellular Ca2+ oscillation in mGluR5-transfected cells
- describe Ca2+ concentration effect on oscillation frequency
- discuss mGluR5 Ca2+ binding site conservation
- describe Ca2+ effect on mGluR5
- discuss potential of Ca2+ to modulate mGluR5
- describe potential therapeutic implications
- discuss family C GPCRs modulation by Ca2+
- describe potential for developing allosteric modulators
- discuss co-activation induced by endogenous agonists and PAMs
- conclude modulation of mGluR1α by Ca2+
- describe experimental methods
- report effects of extracellular Ca2+ on mGluR5 response to L-Glu
- report effects of extracellular Ca2+ on mGluR5 response to Ro-674853
- report effects of extracellular Ca2+ on mGluR5 response to L-Quis
- describe methods for Example 4
- report results of Example 4
- describe activation of mGluR1 by glutamate and calcium
- report results of mGluR1 activation
- define technical and scientific terms
- discuss equivalents to specific embodiments

